CIVETS Medical Device Market Reports

Publisher Name :
Date: 29-Jan-2014
No. of pages: 0

The CIVETS Medical Device Market Reports provide the latest available data, expert analysis and our independent 5-year forecasts for key CIVETS markets. Each country report covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.

Key uses of Medical Devices Reports

  • Forecast the pace and stability of each CIVETS country’s economic and industry growth
  • Identify and evaluate adverse political and economic trends in key markets, to facilitate risk mitigation strategies
  • Assess critical shortcomings of each CIVETS country’s business environment that pose hidden barriers and costs to corporate profitability
  • Contextualise individual CIVETS country risks against their CIVETS regional peers using BMI’s country-comparative risk ratings system
  • Target business opportunities in the key-growth industry sectors
  • Evaluate external threats to doing business in each CIVETS country, including currency volatility, the commodity price boom and protectionist policies

6 Key Markets Covered

Highly detailed analysis providing comprehensive regularly updated reports for leading markets in the region.

CIVETS Medical Device Market Reports

  • Colombia
  • Indonesia
  • Vietnam
  • Egypt
  • Turkey
  • South Africa

CIVETS Medical Device Market Reports

N/A

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Bangladesh Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 110
    BMI View: We consider Bangladesh's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound investment. While we are optimistic that ongoing tax reform efforts by the government will rake in more revenues to support development spending, and keep the country's budget deficit manageable at around 3.0% of GDP over the coming yea......
  • Research Report on Hemodialysis Industry in China, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The dialysis patients are fewer in developing countries but increases rapidly. In recent years, the growth rate o......
  • Central America Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 73
    BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapita medicine spending and strong consumer demand still present strong revenue-generating opportunities for multimodal pharmaceutical companies. Headline Expenditure Projections ? Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revised slightly down since Q314 d......
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets ......
  • Iran Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 115
    BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the market to contract sharply in US dollar terms. While improved international relations have reduced the regulatory risk associated with operating in the market for multinational drugmakers, the recent proclamation of the Islamic State (IS) in neighbouring Iraq and S......
  • Ireland Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 78
    BMI View: The US government and the OECD recent proposals to discourage corporate inversion pose downside risk to the rate of M&A deals that opt to establish their new headquarters' domicile in Ireland, although the megatrend of consolidation within the pharmaceutical industry, including cross-border mergers and redomiciling in Ireland for tax saving purposes, is expected to continue over the near term. More broadly, due to potential acquisitive interest in different Irish pharmaceutical equitie......
  • Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 93
    BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the inherent difficulties of providing infrastructure and access to healthcare in such a large country. However, the government continues to show its commitment to improving healthcare as it allocates more funds to constructing new health clinics across the country. Although Kazakhstan's growing pharmaceutical industry will be driven by demand for generic medicines over the medium term, we believe t......
  • Myanmar Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 61
    BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight that the lack of basic infrastructure and political instability will potentially affect the growth of the economy. Headline Expenditure Projections ? Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014; +19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previous quarter. ? Healthcare Expenditure: MMK1,047.3bn (USD1.1bn) in 2013......
  • Slovenia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 91
    BMI View: Slovenia is facing deflationary pressures on consumer prices, which will impact pharmaceutical spending - especially as an increasing proportion of high-value drugs is met by co-payments. We have therefore downwardly revised our pharmaceutical forecast for 2014. A high budget deficit limits room for the new government to increase funding for health services, and we expect healthcare spending to decline this year and next, before returning to modest growth in 2016. Headline Expenditure ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs